Skip to content
ZEN Global Engine

Zimbabwe Declines ‘Unbalanced’ American Healthcare Assistance Agreement Due to Data Concerns

Medical aid illustration
The proposed US funding would have supported programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

The nation of Zimbabwe has turned down a significant American health deal valued at $367m (272 million pounds) over five years because of Washington's request for sensitive information.

This move was revealed after a internal memorandum dated December was leaked, indicating that Head of State Emmerson Mnangagwa felt the deal was "lopsided".

An official spokesperson has since clarified that the US was requesting genetic material for scientific study and commercial gain but was unwilling to share the benefits from any future vaccines.

"We are forced to start the challenging and unfortunate process of winding down our health aid in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.

The US Embassy said the United States had donated more than $1.9bn in health funding to Zimbabwe over the last twenty years.

A doctors' association in Zimbabwe has appealed for continued talks to find a agreement acceptable to both sides so the country's critical HIV programme can proceed.

Broader Implications

This development comes after a similar situation in neighbouring Kenya, where a high court halted a similar deal with the US following concerns were filed about the security of citizens' health data.

After resuming the presidency last year, US President Donald Trump has reduced overseas assistance and closed the key foreign aid agency.

USAID had managed assistance for the American government, but Trump stated its spending was "inefficient" and his government was seeking direct bilateral agreements to enhance transparency and responsibility.

As per reports, Sixteen African countries have so far signed similar health pacts, constituting over $18.3bn of fresh investment.

Details of the Declined Agreement

The funds for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this collaboration might have yielded immense advantages for Zimbabwean communities, especially the 1.2 million currently on antiretroviral therapy via US-supported initiatives," the Ambassador added.

However, official spokesman Nick Mangwana argued the arrangement was "unfair".

"Our nation was requested to share its biological resources and data over an extended period, with no corresponding assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that shared data," he stated.

"Effectively, our country would provide the raw materials for medical research without any certainty that the resulting innovations would be accessible to our population should a future disease outbreak emerge."

National Interest and International Frameworks

Mangwana further pointed out that the US's withdrawal from the global health body and its pursuit of bilateral deals were undermining structures already set up via the global health agency.

The spokesperson cited its Pandemic Benefit-Sharing scheme designed to deal with future global health emergencies.

"This framework is intended to guarantee that when a nation provides its samples, the benefits – such as medicines and cures – are shared equitably, not commercialised solely by those with the funds to develop them."

These objections over the US deal "must not be interpreted as hostility towards the US," he added.

"We encourage ongoing dialogue with our US partners on how future co-operation might be arranged in a way that honours the sovereignty and dignity of both nations."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it recognised the government's concerns, but recommended that negotiations must proceed given that a large portion of the nation's Aids initiatives relied on international support.

"Where technical issues exist, such as those relating to information security or implementation frameworks, these can frequently be addressed via technical clarification and mutually agreed protections," it said.

The halted deal underscores the continuing challenges between accepting much-needed international aid and protecting a country's data in an increasingly interconnected world.

Written by

Michael Weeks

Lena is a sustainability strategist and innovation advocate, passionate about bridging technology and ecology.

ZEN Global Engine

Type to search articles.